Table 3 Gametocyte carriage by treatment group
CQ | SP | SP-AS | p value | |
|---|---|---|---|---|
Gametocyte prevalence, n (%) | ||||
Day 0 | 79 (7.6) | 77(2.6) | 81(3.7) | 0.31 |
Day 7 | 53 (5.7) | 56(16.1) | 77(3.9) | 0.03 |
Day 14 | 45(6.7) | 47(10.6) | 77(2.6) | 0.18 |
Day 28 | 25(12.0) | 40(10) | 72(0.0) | 0.02 |
Gametocyte incidence, n (%) | ||||
Day 7 | 49(6.1) | 55(16.4) | 75(2.7) | 0.01 |
Day 14 | 41(4.9) | 47(10.6) | 75(2.7) | 0.17 |
Day 28 | 24(12.5) | 40(9.8) | 70(0.0) | 0.02 |
Person-gametocyte-weeks (/1000 person-weeks) | 6/154 (39.0) | 14/187 (74.9) | 5/301 (16.7) | 0.02† |